Key Takeaways
- Record quarter, supercharged by caustic soda: Revenue hit a record ₹556 Crores, up 64% YoY, driven by a 77% jump in caustic soda ECU realizations as global chlorine bottlenecks choked supply.
- Chlorine is the hidden engine: Negative chlorine spreads widened to ₹8–10/kg as producers desperate to run caustic plants dumped derivatives, a dynamic that simultaneously lifted Epigral's caustic realizations and compressed its derivative margins.
- New capacities are live, ramp-up is the next test: All three committed expansions (ECH, CPVC, additional caustic soda) were commissioned on time and on budget; the focus now shifts to ramping them to optimum utilization by Q1 FY2024 for CPVC and Q4 FY2023 for ECH.
- Europe is a real, near-term export opportunity: European caustic prices of €1,500–1,800/tonne make exports feasible despite freight costs, and the company has begun contracting with European and US customers for ECH and CPVC.
- What to watch next quarter: The pace of ECH and CPVC volume ramp-up from January, whether chlorine negative spreads ease after Diwali as expected, and any signal on caustic soda price direction as global recession fears deepen.
The Chlorine-Caustic Tug-of-War
- Global chlorine pain is Epigral's caustic gain: In Europe and the US, recession has crushed demand for chlorine derivatives (PVC, TDI, MDI), but because chlorine cannot be stored, plants must cut run-rates, which constricts caustic soda supply and pushes prices higher.
- Negative chlorine spreads widened sharply: The spread turned more negative this quarter, reaching ₹8–10/kg versus ₹4.5–5/kg last quarter, as peak caustic prices made producers even more desperate to dispose of chlorine derivatives at any cost.
- India's chlorine market is structurally different: Unlike Europe and the US, where chlorine is consumed by a few large petrochemical chains, India's chlorine demand is fragmented across specialty chemicals, water treatment, PVC plasticizers, and chloromethane for pharma and agro, making the bottleneck less severe but still real.
- The bottleneck is expected to ease: Management expects negative chlorine spreads to improve after Diwali and does not see them going further down unless caustic prices rise even more.
Maulik Patel: "If you are not able to sell the chlorine or consume the chlorine, you are not able to produce the caustic soda, so that is why in the world right now if you do not have 100% utilization or the caustic soda plants are running little lower capacity right now, but the same time the caustic price are moving upward."
New Capacity Ramp-Up
- All three projects are live: Epichlorohydrin (ECH), CPVC resin, and additional caustic soda capacity were all commissioned in H1 FY2023, within the original timeline and capex budget. The additional caustic soda came online on September 30.
- Ramp-up timelines are staggered: CPVC is expected to start ramping from December, ECH from January, with both reaching optimum levels by Q1 FY2024 and end of Q4 FY2023 respectively; the new caustic soda capacity should hit optimum in Q4 FY2023.
- Sizable volumes visible soon: Management expects meaningful volume contribution from both ECH and CPVC by the end of Q3 FY2023 or early Q4 FY2023, with the full advantage of all three projects reflected in FY2024.
- Customer approvals are underway: The company has started receiving approvals from customers for both ECH and CPVC, and contracting with European and US customers is in progress during the current contract season.
- ECH uses the glycerol route: The plant employs green-side technology, producing ECH from glycerol rather than propylene, which management positions as a sustainable differentiator.
The European Export Window
- Energy costs have opened a door: European caustic soda prices of €1,500–1,800/tonne make exports from India economically viable despite high transportation costs, because European producers face energy costs that have risen 5–7x.
- Exports are happening now: Epigral has already exported partial quantities of caustic soda to Europe as part of bulk consignments, using vessel-sharing arrangements among 2–3 players to manage the 10,000-tonne vessel size requirement.
- ECH and CPVC are next: The company is targeting both domestic and export markets for ECH, citing better realizations in Europe and the US compared to Asia, and has begun adding infrastructure in those regions.
- Diversification is a deliberate strategy: Even if domestic and export realizations were similar, management would still pursue a balanced approach to de-risk the business model.
Maulik Patel: "Many opportunities arise, because of the European energy prices and the situation, many downstream companies, it is not feasible so the caustic soda price in Europe is such that many downstream chemical is becoming unviable also, so there are opportunities also in the Europe and US and there are better realization also compared to Asia."
Chlorine Integration: The 80% Target
- The strategy is to lock in chlorine: Management's stated goal is to reach 85% chlorine integration (including pipeline customers) within three years, up from the current 60–65%, by adding downstream chemistries that consume chlorine, hydrogen, and other raw materials.
- 15–20% will stay with flow customers: The company deliberately plans to keep 15–20% of chlorine going to continuous external customers as a buffer, so that if a derivative unit goes down, it does not face the overnight chlorine disposal crisis now plaguing European and US producers.
- Chlorotoluene is the next identified derivative: Expansion of Chlorotoluene and its value chain is on track for completion by Q4 FY2024, with additional downstream derivatives to follow under a separate capex plan.
- The 50:50 revenue mix target is delayed by caustic prices: The long-term goal is to shift the revenue mix from the current ~75% Chlor-Alkali / 25% derivatives toward 50:50, but abnormally high caustic soda realizations are currently inflating the Chlor-Alkali share and delaying the ratio shift.
Maulik Patel: "Our strategy is very clear... in next three years our focus is 100% on the derivative side where our priority is to consume chlorine up to 85% of producing including the pipeline customers, but the 15% chlorine we are going to send to our consumers continuously, because any in the future in the backup something goes down in the derivative segment definitely overnight you cannot find the customers for the chlorine."
Margins & Financial Position
- EBITDA margin dipped QoQ but stayed strong: Margin moved from 35% to 33% sequentially because caustic soda realizations softened marginally while raw material prices held firm; H1 averaged ~33%, above the guided 26–30% range.
- Long-term margin guidance is 28% ±2%: Management expects to achieve this band for ECH and CPVC in the longer run, but the current environment of abnormally high caustic prices makes it difficult.
- Debt reduction continued: Long-term debt fell to ₹856 Crores from ₹909 Crores, despite new borrowing for commissioned projects, and the debt-to-EBITDA ratio improved sharply to 1.3x from 2.5x.
- Short-term borrowing rose on higher working capital: The increase versus last year reflects the higher operational scale from new plants coming online, not distress; working capital days are expected to stay in the 45–60 day range.
- Returns improved materially: ROCE rose to 37% from 29%, and ROI to 50% from 36% in FY2022, driven by higher realizations.
- Land acquisition was funded internally: The purchase of 2.89 lakh square meters of adjacent land in Dahej cost approximately ₹160 Crores and was paid from internal accruals; no activity is planned on it for the next three years.
Demand Environment & End-Markets
- Caustic soda demand is broad-based and resilient: Demand comes from diversified industries (alumina, agro intermediates, pharma intermediates, detergents, soaps, paper, water treatment) and is consumption-driven, so it has not been affected by recession.
- Textile demand is soft but expected to recover: Textile demand is down, but management expects it to pick up after Diwali as cotton prices decline. Paper demand, by contrast, is positive, and hydrogen peroxide demand is good worldwide.
- CPVC is a domestic story: With 50% of global CPVC demand located in India, the company's CPVC strategy is 100% domestic-focused, with pricing kept at par with international suppliers.
- China ECH exports are seen as temporary: Management believes the current wave of Chinese ECH exports will reverse once China's domestic demand recovers, noting that six months ago China was not exporting significant quantities.
- Global slowdown is a headwind, partially offset: International chemical prices have come down across the board, which affects Epigral, but the European energy situation is simultaneously creating positive tailwinds for caustic soda.
Maulik Patel: "I believe that in India, I keep telling that India is now in a stage where every year we required a sizable like around 400 to 500 tonnes per day size of the plant is required in India, because of the caustic consumption as well as chlorine derivative consumption... One sizeable plant is required in India now every year."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY2023 guidance | Confident to achieve previously given FY2023 guidance despite current market dynamics | FY2023 |
| ECH ramp-up | Reach optimum capacity utilization | End of Q4 FY2023 |
| CPVC ramp-up | Reach optimum capacity utilization | Q1 FY2024 |
| New caustic soda capacity | Reach optimum utilization of capacity commissioned Sep 30 | Q4 FY2023 |
| Chlorotoluene expansion | Complete expansion of Chlorotoluene and value chain | Q4 FY2024 |
| R&D facility | Dedicated R&D facility ready | Q2 FY2024 |
| Chlorine integration | Reach 80% chlorine integration (including pipeline customers) | Next 3 years |
| Revenue mix | Reach 50% Chlor-Alkali / 50% derivatives | Next 3 years |
| Preference share redemption | Redeem Meghmani Organics shares completely | 5 years (by FY2027) |
| FY2027 revenue target | Reach ₹5,000 Crores | FY2027 |
| EBITDA margin | 28% plus/minus 2% (26–30%) | Long-run |
| Working capital days | Maintain 45–60 day range | Next few years |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Revenue | ₹556 cr, +64% YoY |
| EBITDA | ₹180 cr, +79% YoY |
| EBITDA margin | 32%, vs 33% QoQ; caustic realization dipped while raw material costs held |
| PAT | ₹92 cr, +95% YoY |
| PAT margin | 16% |
| Chlor-Alkali segment revenue growth | +86% YoY |
| Chlor-Alkali capacity utilization | 85% |
| Chloromethane capacity utilization | 104% |
| Hydrogen Peroxide capacity utilization | 97% |
| ECU realization – caustic soda | +77% YoY |
| ECU realization – caustic potash | +120% YoY |
| Return on capital employed | 37%, improved from 29% in FY2022 |
| Return on investment | 50%, improved from 36% in FY2022 |
| Long-term debt | ₹856 cr as of Sep 30, 2022, reduced from ₹909 cr as of Mar 31, 2022 |
| Debt to EBITDA ratio | 1.3x, down from 2.5x in Q2 FY22 |
| EBITDA margin guidance | 28% ± 2% (26% to 30%) |
| Revenue mix – Chlor-Alkali | 75% of H1 FY23 revenue |
| Revenue mix – Derivatives | 25% of H1 FY23 revenue |
| Chlorine integration level | 60–65% including ECH and CPVC ramp-up |
| Chlorine negative spread | ₹8,000–₹10,000 per tonne, vs ₹4,500–₹5,000 per kg last quarter |
| Caustic soda domestic price | ~₹60,000 per tonne; net ECU realization ~₹48,000–₹50,000 after chlorine |
| ECH expected export realization | ~₹180 per kg on index-based contracts |
| Land acquired in Dahej | 2.889 lakh sq m, purchased for ~₹160 cr from internal accruals |
| Preference shares redeemed | ₹12 cr in Q2 FY23; full redemption targeted by FY2027 |
| Working capital days | 45–60 days |